JEAN JACQUES BIENAIME Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of JEAN JACQUES BIENAIME for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2015 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 26.13 | 5,604 | 146,433 | 5,604 | |
| Mar 24 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 126.40 | 1,000 | 126,396 | 33,258 | 34.3 K to 33.3 K (-2.92 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 124.87 | 1,000 | 124,866 | 34,258 | 35.3 K to 34.3 K (-2.84 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 123.48 | 1,000 | 123,477 | 35,258 | 36.3 K to 35.3 K (-2.76 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 15,000 | 194,850 | 46,500 | |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 114.89 | 2,021 | 232,201 | 36,258 | 38.3 K to 36.3 K (-5.28 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 112.14 | 4,000 | 448,574 | 38,279 | 42.3 K to 38.3 K (-9.46 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 112.12 | 15,000 | 1,681,809 | 42,279 | 57.3 K to 42.3 K (-26.19 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 15,000 | 194,850 | 57,279 | 42.3 K to 57.3 K (+35.48 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 51,500 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 108.36 | 90,500 | 9,806,580 | 90,500 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 113.70 | 10,000 | 1,137,016 | 42,279 | 52.3 K to 42.3 K (-19.13 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 52,279 | 42.3 K to 52.3 K (+23.65 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 39,600 | 0 | 254,757 | 215.2 K to 254.8 K (+18.41 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 3,000 | 38,970 | 61,500 | |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 107.71 | 916 | 98,660 | 42,279 | 43.2 K to 42.3 K (-2.12 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 9.86 | 500 | 4,930 | 43,695 | 43.2 K to 43.7 K (+1.16 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 107.42 | 5,000 | 537,097 | 215,157 | 220.2 K to 215.2 K (-2.27 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 108.44 | 5,000 | 542,195 | 220,157 | 225.2 K to 220.2 K (-2.22 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 107.96 | 3,000 | 323,893 | 43,195 | 46.2 K to 43.2 K (-6.49 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 3,000 | 38,970 | 46,195 | 43.2 K to 46.2 K (+6.95 %) |